Product
Supplier
Encyclopedia
Inquiry
Home > Chemicals Market Price & Insight > Jiangxi Bestcare Pharmaceuticals invested 260 million yuan to expand the project of hormone raw material intermediates such as cortisone acetate and canrenone intermediates
— Share —

Jiangxi Bestcare Pharmaceuticals invested 260 million yuan to expand the project of hormone raw material intermediates such as cortisone acetate and canrenone intermediates

healthoo 2021-03-10
The environmental impact assessment report of the production line expansion project of Jiangxi Best Kangrui Pharmaceutical Co., Ltd. with an annual output of 200 tons of cortisone acetate

Please sign in to view all content or subscribe.

Comment
Comment

Trade Alert

Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.